General MedicationsORALStandard

RILPIVIRINE HYDROCHLORIDE

Standard Dose

EQ 25MG BASE

Max Dose

Refer to approved labeling

Primary Use

Review priority: STANDARD Marketing status: Prescription

Summary

Approval overview RILPIVIRINE HYDROCHLORIDE is listed in Drugs@FDA under application 218798 (ANDA).

Review priority: STANDARD Marketing status: Prescription Active ingredient RILPIVIRINE HYDROCHLORIDE Form and strength TABLET;ORAL - EQ 25MG BASE Sponsor SOMERSET THERAPS LLC Submission history Latest submission status date: 2026-01-29 00:00:00.

Structured Monograph

Clinical summary

Approval overview RILPIVIRINE HYDROCHLORIDE is listed in Drugs@FDA under application 218798 (ANDA). Review priority: STANDARD Marketing status: Prescription Active ingredient RILPIVIRINE HYDROCHLORIDE Form and strength TABLET;ORAL - EQ 25MG BASE Sponsor SOMERSET THERAPS LLC Submission history Latest submission status date: 2026-01-29 00:00:00. Submission type: ORIG.

Monitoring

• Marketing status: Prescription
• Review priority: STANDARD

Interaction Notes

No interaction notes stored yet.